"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops.
Today's guests: Emmanuel Cau, Barclays Head of European and APAC Equity Strategy, Negah Angha, King's College London Visiting Fellow; Mike Doustdar, Novo Nordisk CEO; Morris Reid, Actum Partner (Source: Bloomberg)
Defense stocks slid on both sides of the Atlantic as Democrats’ landslide win in US midterm elections dented expectations of a further ramp-up in the country’s military spending.
India overhauled a short-term military recruitment plan by extending conscripts’ tenure and offering a path to permanent employment as border tensions with China and Pakistan continue to pressure the country’s defense establishment.
India’s coffee output is likely to fall short of an earlier forecast as below-normal rains during the four-month monsoon season took a toll on crops, according to the Coffee Board.
Innovation in Switzerland’s pharmaceutical industry has fallen for the second year in a row, a new study shows, underscoring how it is trailing foreign competitors in digital research and clinical trials.
Boehringer Ingelheim GmbH signed a licensing deal potentially worth more than $7 billion with China’s Sino Biopharmaceutical Limited and its subsidiaries for experimental cancer treatments.
Novo Nordisk A/S Chief Executive Officer Mike Doustdar discusses the possible launch of a new obesity drug called CagriSema. "We are hopeful that we will be able to get the timely approval from the FDA at the end of this year and launch it at the beginning of next year," Doustdar says. He speaks on Bloomberg Television after the company boosted its forecast for the year once again, sparking optimism after the new Wegovy pill and the older shot Ozempic helped buoy earnings. (Source: Bloomberg)
Saudi Arabia is pressing ahead with an overhaul of listing rules despite warnings from banks and industry bodies the changes risk making it harder for firms to go public.
A Fidelity International fund manager is buying the dip in technology stocks and adding some India exposure, treating the selloff driven by concerns over US midterm elections as a buying opportunity.
A Canadian body that provides financing for Indigenous groups issued its largest-ever bond, and expects to ramp up activity quickly to pay for a flurry of planned resource and infrastructure projects.
BMW will speed up the rollout of new models, betting the move will help counter a slump in China after another profit warning. Bloomberg's Elisabeth Behrmann reports.
(Corrects spelling of reporter's name in on-screen graphic.) (Source: Bloomberg)
Agricultural commodities trader Olam Agri is boosting investment in African food supply chains to tap the continent’s dietary shift toward more meat and processed products.
Indian officials were cautious on the US midterm election results, saying it eases some of the pressure over trade tensions but creates a new layer of uncertainty in an already fragile relationship.
Anna Edwards, Guy Johnson, and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade." (Source: Bloomberg)
India’s central bank announced a new technical panel to examine the efficiency, liquidity and resilience of the country’s foreign exchange and government bond markets.
Encube Ethicals Pvt., backed by private equity firm Quadria Capital, is preparing for an initial public offering in Mumbai as soon as this month that could raise about 30 billion rupees ($317 million), according to people familiar with the matter.
Some of the world’s biggest hedge funds warned that risks are growing in private credit, adding to debate about how rising interest rates will impact the asset class after scrutiny intensified this year.
Bharat Heavy Electricals Ltd. secured contracts worth as much as 280 billion rupees ($3 billion) for supplying equipment to Adani Power Ltd., underscoring an increase in private-sector spending on new capacity.